Together Pharma Ltd (TGTR.TA)
ILA 421.9
(-1.29%)
ILA 421.9
(-1.29%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -4.31 Million ILS | 87.13% |
| 2022 | -33.52 Million ILS | -143.35% |
| 2021 | -13.77 Million ILS | -292.62% |
| 2020 | 7.15 Million ILS | 146.82% |
| 2019 | -15.27 Million ILS | 89.81% |
| 2018 | -149.86 Million ILS | -440673.53% |
| 2017 | -34 Thousand ILS | 98.04% |
| 2016 | -1.73 Million ILS | 54.83% |
| 2015 | -3.83 Million ILS | 29.84% |
| 2014 | -5.47 Million ILS | -22.01% |
| 2013 | -4.48 Million ILS | 65.43% |
| 2012 | -12.97 Million ILS | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 3.18 Million ILS | 171.33% |
| 2024 Q2 | 3.18 Million ILS | 0.0% |
| 2023 Q2 | 2.3 Million ILS | 0.0% |
| 2023 Q3 | -4.46 Million ILA | -293.7% |
| 2023 Q4 | -4.46 Million ILS | 0.0% |
| 2023 FY | -4.31 Million ILS | 87.13% |
| 2023 Q1 | 2.3 Million ILS | 124.29% |
| 2022 FY | -33.52 Million ILS | -143.35% |
| 2022 Q1 | -7.27 Million ILS | -55.41% |
| 2022 Q2 | -7.27 Million ILS | 0.0% |
| 2022 Q3 | -9.48 Million ILS | -30.26% |
| 2022 Q4 | -9.48 Million ILS | 0.0% |
| 2021 FY | -13.77 Million ILS | -292.62% |
| 2021 Q4 | -4.68 Million ILS | -20.72% |
| 2021 Q3 | -3.88 Million ILS | -6.68% |
| 2021 Q2 | -3.63 Million ILS | -130.92% |
| 2021 Q1 | -1.57 Million ILS | 68.56% |
| 2020 Q3 | 8.24 Million ILS | 62.06% |
| 2020 Q2 | 5.08 Million ILS | 535.16% |
| 2020 FY | 7.15 Million ILS | 146.82% |
| 2020 Q1 | -1.16 Million ILS | 61.23% |
| 2020 Q4 | -5.01 Million ILS | -160.77% |
| 2019 Q1 | -4.62 Million ILS | -58.0% |
| 2019 Q4 | -3.01 Million ILS | 0.0% |
| 2019 FY | -15.27 Million ILS | 89.81% |
| 2019 Q2 | -4.62 Million ILS | 0.0% |
| 2019 Q3 | -3.01 Million ILS | 34.78% |
| 2018 Q4 | -2.92 Million ILS | 0.0% |
| 2018 Q1 | -72 Million ILS | -719955.0% |
| 2018 Q2 | -72 Million ILS | 0.0% |
| 2018 FY | -149.86 Million ILS | -440673.53% |
| 2018 Q3 | -2.92 Million ILS | 95.94% |
| 2017 Q2 | -7000.00 ILS | 0.0% |
| 2017 FY | -34 Thousand ILS | 98.04% |
| 2017 Q4 | -10 Thousand ILS | 0.0% |
| 2017 Q3 | -10 Thousand ILS | -42.86% |
| 2017 Q1 | -7000.00 ILS | 99.8% |
| 2016 Q4 | -3.52 Million ILS | -896.04% |
| 2016 Q2 | -841.04 Thousand ILS | -4570.31% |
| 2016 Q3 | 442.37 Thousand ILS | 152.6% |
| 2016 Q1 | 18.81 Thousand ILS | 104.69% |
| 2016 FY | -1.73 Million ILS | 54.83% |
| 2015 FY | -3.83 Million ILS | 29.84% |
| 2015 Q2 | 56.6 Thousand ILS | 108.37% |
| 2015 Q1 | -676.27 Thousand ILS | -63.74% |
| 2015 Q3 | -525.42 Thousand ILS | -1028.2% |
| 2015 Q4 | -401.33 Thousand ILS | 23.62% |
| 2014 Q3 | -1.58 Million ILS | 27.61% |
| 2014 Q1 | -802.7 Thousand ILS | 49.24% |
| 2014 FY | -5.47 Million ILS | -22.01% |
| 2014 Q4 | -413 Thousand ILS | 73.92% |
| 2014 Q2 | -2.18 Million ILS | -172.58% |
| 2013 Q2 | -632.65 Thousand ILS | 42.36% |
| 2013 FY | -4.48 Million ILS | 65.43% |
| 2013 Q3 | -1.27 Million ILS | -101.78% |
| 2013 Q4 | -1.58 Million ILS | -23.86% |
| 2013 Q1 | -1.09 Million ILS | -34.23% |
| 2012 Q4 | -817.68 Thousand ILS | 91.61% |
| 2012 FY | -12.97 Million ILS | 0.0% |
| 2012 Q3 | -9.74 Million ILS | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Cannabotech LTD | -16.12 Million ILA | 73.229% |